By Device Type:
Based on type, the market is segmented into Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, IUD and Other Devices. A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. They also to a lesser extent protect against genital herpes, human papillomavirus (HPV), and syphilis. Therefore, with the increasing rate of STDs, there will be a rapid increase in the demand for the contraceptives, which ultimately drives the market.
By End User:
Based on end user, the market is classified into male and female. The male segment is expected to have a better growth rate during the forecast period. This is due to the increasing number of male birth control devices being commercialized. The female segment is anticipated to exhibit lucrative growth across the forecast period majorly due to the increasing rates of unwanted pregnancies. Additionally, the increasing government initiatives to lower the rates of unwanted pregnancies will further propel the segmental growth.
By Distribution Channel:
Based on distribution channel, the market is segmented into hospital, retail and online pharmacies. The retail pharmacies segment is expected to hold the maximum share during the forecast period in the market. This is due to the improved supply chain network of manufacturers. The online channel segment is anticipated to exhibit significant growth during the forecast period majorly on account of the growing accessibility to over-the-counter drugs on the online platform. Also, increasing awareness among the population pertaining to several novel birth control pills will further boost product demand.
The market studied is moderately competitive and there are several international players that are operating in Brazil Contraceptive devices market. The players in the Brazil contraceptive devices market are Allergan PLC, Bayer AG, Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Reckitt Benckiser Group plc, The Cooper Companies Inc, and Veru Inc.